par Richeldi, Luca;Azuma, Arata;Cottin, Vincent;Kreuter, Michael;Maher, Toby TM;Martínez, Fernando Prados;Oldham, Justin M;Valenzuela, Claudia;Clerisme-Beaty, Emmanuelle;Gordat, Maud;Wachtlin, Daniel;Liu, Yan;Schlecker, Christina;Stowasser, Susanne;Zoz, Donald F;Wijsenbeek, Marlies S;Bondue, Benjamin 
Référence The New England journal of medicine, 392, 22, page (2193-2202)
Publication Publié, 2025-06-01
Référence The New England journal of medicine, 392, 22, page (2193-2202)
Publication Publié, 2025-06-01
Article révisé par les pairs
| Titre: |
|
| Auteur: | Richeldi, Luca; Azuma, Arata; Cottin, Vincent; Kreuter, Michael; Maher, Toby TM; Martínez, Fernando Prados; Oldham, Justin M; Valenzuela, Claudia; Clerisme-Beaty, Emmanuelle; Gordat, Maud; Wachtlin, Daniel; Liu, Yan; Schlecker, Christina; Stowasser, Susanne; Zoz, Donald F; Wijsenbeek, Marlies S; Bondue, Benjamin |
| Informations sur la publication: | The New England journal of medicine, 392, 22, page (2193-2202) |
| Statut de publication: | Publié, 2025-06-01 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Aged |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Double-Blind Method | |
| Idiopathic Pulmonary Fibrosis -- diagnosis -- drug therapy -- physiopathology | |
| Lung -- physiopathology | |
| Phosphodiesterase 4 Inhibitors -- administration & dosage -- adverse effects | |
| Vital Capacity -- drug effects | |
| Antifibrotic Agents -- administration & dosage -- adverse effects | |
| Treatment Outcome | |
| Disease Progression | |
| Dose-Response Relationship, Drug | |
| Tablets | |
| Administration, Oral | |
| Cyclobutanes | |
| Indoles | |
| Pyridones | |
| Organic Chemicals | |
| Piperidines | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0028-4793 |
| info:doi/10.1056/NEJMoa2414108 | |
| info:pmid/40387033 |
